Description and <i>In silico</i> ADME Studies of US-FDA Approved Drugs orDrugs under Clinical Trial which Violate the Lipinski’s Rule of 5Niyatha Lohit, Pradeep Kumar, Adarsh Kumar et al.|Letters in Drug Design & Discovery|2023Cited by 52